Turbogen Ltd. submitted a Form F-1 registration statement to the U.S. Securities and Exchange Commission as part of its effort to secure a listing on the Nasdaq Capital Market, the company said in a statement.
The Israeli developer of multi-fuel microturbine technology said it plans to complete a dual listing process within the coming weeks and will pursue the Nasdaq listing without conducting a traditional U.S. underwritten initial public offering.
According to the filing, once the registration statement is declared effective Turbogen intends to execute a $7.5 million financing transaction. The funding round is expected to be led by investor Alex Katz and will be structured as a strategic private placement together with the exercise of shareholder-approved options granted on November 25, 2025.
The company also disclosed that controlling shareholder Anglo Turbo recently increased its position by acquiring roughly $2.25 million of additional shares.
Turbogen manufactures multi-fuel microturbine systems intended for on-site electricity and heat generation, with the U.S. and European markets identified as primary targets. The firm describes its Combined Heat and Power - CHP - systems as engineered to raise building energy utilization while reducing greenhouse gas emissions and operational costs.
In its statement the company said it has signed long-term contracts to supply microturbine systems to entities in the U.S. and Europe, though it did not provide specific details about those agreements.
"We are entering the U.S. capital markets at an ideal juncture, backed by proven technology and a surging demand for independent, green energy solutions," said CEO Yaron Gilboa.
The company indicated the information was provided in a press release from Turbogen Ltd.
For market participants and potential investors, the filing outlines a pathway to public listing that relies on a registration statement becoming effective rather than a conventional underwritten IPO. The planned private placement and option exercises form the immediate financing mechanism tied to that regulatory milestone. Turbogen's product proposition centers on on-site generation and CHP benefits, while recent contractual wins and the controlling shareholder's additional share purchases are highlighted as company developments in the filing.